Fermagate

DRUG4 trials

Sponsors

Ineos Healthcare Limited

Conditions

Chronic Kidney Failure

Phase 2

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

CompletedNCT00317694

Ineos Healthcare LimitedChronic Kidney Failure

Start: 2006-03-31End: 2007-06-30Updated: 2009-08-10

An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate

TerminatedNCT00358722

Ineos Healthcare LimitedChronic Kidney Failure

Start: 2006-07-31End: 2008-06-30Updated: 2009-08-10

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

CompletedNCT00436683

Ineos Healthcare LimitedChronic Kidney Failure

Start: 2007-02-28End: 2008-04-30Updated: 2009-08-10

Phase 3

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

TerminatedNCT00844662

Ineos Healthcare LimitedChronic Kidney Failure

Start: 2009-07-31End: 2011-10-31Target: 1000Updated: 2010-10-19